Secukinumab Sustains Individual Clinical Responses Over Time in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S21, 2018. DOI: 10.25251/skin.2.supp.21. Disponível em: https://skin.dermsquared.com/skin/article/view/293. Acesso em: 17 apr. 2026.